Onsite Fungal Infection Diagnostic Laboratory
Certified, Focused + Specialized Fungal RL (Reference Lab)
MiraVista Diagnostics’ fungal RL (reference lab) is certified by CAP and CLIA. It is exclusively focused on processing diagnostic tests for serious fungal infections and specializes in a comprehensive menu of fungal antigen and antibody detection tests.
Our experienced clinical laboratory scientists handle, process and analyze over 100,000 diagnostic tests each year and our team of quality assurance specialists are responsible for our fungal infection diagnostic laboratory’s adherence to internal standard operating practices and compliance with industry regulations for infectious disease control, sample integrity, testing procedures, documentation, environmental responsibility and workplace safety.
Coccidioides Study Group San Antonio, TX April 5-6, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT The 68th Annual Coccidioidomycosis Study Group will take place April 5th-April 6th, 2024 in San…
READ MORE →
ATS 2024 International Conference San Diego, CA May 17-22, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT ATS 2024 showcases the latest advances and discoveries in respiratory science, patient care and global…
READ MORE →
American Transplant Congress 2024 Philadelphia, PA June 1-5, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT The American Transplant Congress (ATC) brings together the people and organizations who are redefining the…
READ MORE →
American College of Chest Physicians Boston, MA October 6-9, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT This event will bring you the most up-to-date education in clinical pulmonary, critical care,…
READ MORE →
ID WEEK Los Angeles, CA October 16-20, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT Surround yourself with the ID experts who are advancing the field of ID. Choose scientific programming that’s…
READ MORE →
MiraVista Institutional Biosafety Committee (IBC) Announcement
In compliance with NIAID/NIH guidelines research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →
